Cargando…

Low-Dose Prasugrel in Treatment of Cerebral Aneurysms

Detalles Bibliográficos
Autor principal:	Kang, Hyun-Seung
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Korean Society of Interventional Neuroradiology 2018
Materias:	Commentary
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6132034/ https://www.ncbi.nlm.nih.gov/pubmed/30196684 http://dx.doi.org/10.5469/neuroint.2018.01092

Ejemplares similares

Low-Dose Prasugrel in Patients with Resistance to Clopidogrel for the Treatment of Cerebral Aneurysms
por: Lee, Dongwhane, et al.
Publicado: (2018)

Low-dose Prasugrel in Patients with Resistance to Clopidogrel for the Treatment of Cerebral Aneurysms: Follow-up of over 6 Months
por: Lee, Dongwhane, et al.
Publicado: (2019)

Variability of response on prophylactic prasugrel for endovascular treatment of intracranial aneurysms: Clinical implications
por: Hong, Noah, et al.
Publicado: (2023)

Comparison of lower loading dose of prasugrel with conventional loading dose of prasugrel in Indian patients undergoing percutaneous coronary interventions
por: Kumari, Priti, et al.
Publicado: (2018)

Lower Loading Dose of Prasugrel Compared with Conventional Loading Doses of Clopidogrel and Prasugrel in Korean Patients Undergoing Elective Coronary Angiography: A Randomized Controlled Study Evaluating Pharmacodynamic Efficacy
por: Lee, Dong Hyun, et al.
Publicado: (2014)

Bleeding events and maintenance dose of prasugrel: BLESS pilot study
por: Carrabba, Nazario, et al.
Publicado: (2016)

Ischemic and Bleeding Events Among Patients With Acute Coronary Syndrome Associated With Low-Dose Prasugrel vs Standard-Dose Clopidogrel Treatment
por: Shoji, Satoshi, et al.
Publicado: (2020)

Prasugrel for the treatment of patients with acute coronary syndrome
por: Marzot, Filippo, et al.
Publicado: (2009)

Eversion endarterectomy under full prasugrel treatment
por: Kotsis, Thomas, et al.
Publicado: (2017)

Intraoperative angiography should be standard in cerebral aneurysm surgery
por: Friedman, Jonathan A, et al.
Publicado: (2009)

Randomized Comparison of the Platelet Inhibitory Efficacy between Low Dose Prasugrel and Standard Dose Clopidogrel in Patients Who Underwent Percutaneous Coronary Intervention
por: Jin, Han-Young, et al.
Publicado: (2014)

Prasugrel in critically ill patients
por: Schoergenhofer, Christian, et al.
Publicado: (2017)

Successful Prasugrel Rescue Therapy in Clopidogrel Resistant Patients Who Had Recurrent Stent Thrombosis of Drug-Eluting-Stent: The Role of Prasugrel in Clopidogrel Nonresponders
por: Lee, Seung-Hyun, et al.
Publicado: (2013)

Prasugrel-Induced Hypersensitivity Skin Reaction
por: Kim, Soo-Han, et al.
Publicado: (2014)

Prasugrel for Secondary Prevention of Thrombotic Stroke
por: Yagita, Yoshiki
Publicado: (2023)

Review of Prasugrel for the Secondary Prevention of Atherothrombosis
por: Spinler, Sarah A., et al.
Publicado: (2009)

Time Course of Ischemic and Bleeding Burden in Elderly Patients With Acute Coronary Syndromes Randomized to Low‐Dose Prasugrel or Clopidogrel
por: Crimi, Gabriele, et al.
Publicado: (2019)

Simultaneous Endovascular Treatment of Ruptured Cerebral Aneurysms and Vasospasm
por: Cho, Young Dae, et al.
Publicado: (2015)

Reduction of thromboembolic complications during the endovascular treatment of unruptured aneurysms by employing a tailored dual antiplatelet regimen using aspirin and prasugrel
por: Higashiguchi, Saeko, et al.
Publicado: (2021)

Keyhole Approach and Neuroendoscopy for Cerebral Aneurysms
por: Cho, Won-Sang, et al.
Publicado: (2017)

TRITON and Beyond: New Insights into the Profile of Prasugrel
por: Jakubowski, Joseph A, et al.
Publicado: (2012)

Critical Review of Prasugrel for Formulary Decision Makers
por: Schafer, Jeremy
Publicado: (2009)

The Usefulness of Prasugrel as Rescue Medication in Neuroendovascular Therapy
por: Niimi, Jun, et al.
Publicado: (2020)

No Pharmacokinetic Drug–Drug Interaction Between Prasugrel and Vorapaxar Following Multiple‐Dose Administration in Healthy Volunteers
por: Anderson, Matt S., et al.
Publicado: (2017)

Prasugrel, a new medicine for preventing blockages in the arteries
por: Wang, Zhi-Mei, et al.
Publicado: (2010)

Pharmacokinetic Interaction Between Prasugrel and Ritonavir in Healthy Volunteers
por: Ancrenaz, Virginie, et al.
Publicado: (2013)

The Pharmacokinetics and Pharmacodynamics of Prasugrel and Clopidogrel in Healthy Japanese Volunteers
por: Umemura, Kazuo, et al.
Publicado: (2016)

Evaluation of the Pharmacokinetics and Pharmacodynamics of Prasugrel in Japanese Elderly Subjects
por: Hasunuma, Tomoko, et al.
Publicado: (2017)

Safety and Efficacy of Prasugrel Administration in Emergent Endovascular Treatment for Intracranial Atherosclerotic Disease
por: Asai, Katsunori, et al.
Publicado: (2023)

Low-Dose Immunotherapy: Is It Just an Illusion?
por: Meriggi, Fausto, et al.
Publicado: (2023)

Prasugrel-Based De-Escalation in Patients With Acute Coronary Syndrome According to Renal Function
por: Yun, Jun Pil, et al.
Publicado: (2023)

Low-Dose Ionizing Radiation Therapy: A Novel Treatment for Post-Concussion Syndrome?
por: Oakley, Paul A.
Publicado: (2021)

A Japanese Dose of Prasugrel versus a Standard Dose of Clopidogrel in Patients with Acute Myocardial Infarction from the K-ACTIVE Registry
por: Mori, Hiroyoshi, et al.
Publicado: (2022)

What Role for Biologically Based Dose–Response Models in Estimating Low-Dose Risk?
por: Crump, Kenny S., et al.
Publicado: (2010)

Diabetes mellitus and platelet reactivity in patients under prasugrel or ticagrelor treatment: an observational study
por: Alexopoulos, Dimitrios, et al.
Publicado: (2015)

Differential impact of diabetes mellitus on antiplatelet effects of prasugrel and clopidogrel
por: Niijima, Satoshi, et al.
Publicado: (2018)

Oral antiplatelet therapy in diabetes mellitus and the role of prasugrel: an overview
por: Hillegass, William B, et al.
Publicado: (2011)

Stability-indicating HPLC Method for Simultaneous Determination of Aspirin and Prasugrel
por: Patel, Shital M., et al.
Publicado: (2013)

Implications of the Antiplatelet Therapy Gap Left With Discontinuation of Prasugrel in Canada
por: Lordkipanidzé, Marie, et al.
Publicado: (2020)

Low Dose Medicine: theoretical background and scientific evidence
por: Bernasconi, S.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_ngni9dhsh95tkdj7dj29pvn6uk